Department of Population Health, New York University Langone Medical Center, New York, NY, United States.
New York University College of Dentistry, New York, NY, United States.
Drug Alcohol Depend. 2017 Dec 1;181:208-212. doi: 10.1016/j.drugalcdep.2017.09.033. Epub 2017 Oct 20.
Amphetamine is the most prevalent prescription stimulant in the United States, both medically and nonmedically. Reliable data on nonmedical use is needed to continue to inform prevention. To determine whether adolescents accurately self-report nonmedical amphetamine use, we compared self-reports of nonmedical amphetamine use and nonmedical Adderall use in a national sample.
We examined self-reported nonmedical Adderall and amphetamine use in a nationally representative sample of 24,740 high school seniors in the Monitoring the Future study (2010-2015). We examined prevalence and correlates of discordant responses among past-year Adderall users, defined as reporting past-year nonmedical Adderall use, but not reporting past-year nonmedical amphetamine use.
While 6.9% reported nonmedical Adderall use and 7.9% reported nonmedical amphetamine use, over a quarter (28.7%) of Adderall users reported no amphetamine use. Those at highest risk for Adderall use tended to be at lower odds of providing a discordant response. Older students (aged ≥18), black students, and those with parents of lower educational attainment were more likely to report no amphetamine use, despite reporting Adderall use. Lifetime use of various drugs was associated with decreased odds of providing a discordant response; however, only nonmedical opioid use was associated with significant decreased odds in multivariable models. Disapproval towards amphetamine use increased odds of providing a discordant response, while higher exposure to users decreased odds of providing a discordant response.
Prevalence of nonmedical amphetamine use may be underreported on some surveys, particularly among specific subpopulations. Future surveys must ensure accurate and consistent responses.
安非他命是美国最常见的处方兴奋剂,无论是医疗用途还是非医疗用途。为了继续为预防措施提供信息,需要有可靠的数据来了解非医疗用途。为了确定青少年是否准确地自我报告非医疗用途的安非他命使用情况,我们比较了全国性样本中自我报告的非医疗用途安非他命使用情况和非医疗用途阿得拉使用情况。
我们在监测未来研究(2010-2015 年)的一个全国代表性的 24740 名高中高年级学生样本中检查了自我报告的非医疗用途阿得拉和安非他命使用情况。我们检查了过去一年阿得拉使用者中不一致反应的流行率和相关性,定义为报告过去一年非医疗用途阿得拉使用,但未报告过去一年非医疗用途安非他命使用。
虽然有 6.9%的人报告非医疗用途阿得拉使用,7.9%的人报告非医疗用途安非他命使用,但超过四分之一(28.7%)的阿得拉使用者报告没有安非他命使用。那些最有可能使用阿得拉的人,提供不一致反应的可能性较低。年龄较大的学生(年龄≥18 岁)、黑人学生和父母教育程度较低的学生,尽管报告使用阿得拉,但更有可能报告没有使用安非他命。各种药物的终身使用与提供不一致反应的可能性降低有关;然而,只有非医疗用途的阿片类药物使用与多变量模型中的显著降低的可能性有关。对安非他命使用的不赞成增加了提供不一致反应的可能性,而更高的使用者暴露则降低了提供不一致反应的可能性。
在某些调查中,非医疗用途安非他命的使用频率可能被低估,特别是在某些特定的亚人群中。未来的调查必须确保准确和一致的反应。